Clinical trials
Cerebral Hemorrhage trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 8 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Capital Medical University | 5 |
| Beijing Tiantan Hospital | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Beijing Neurosurgical Institute | 2 |
| Guangzhou University of Traditional Chinese Medicine | 2 |
| Ministry of Science and Technology of the People´s Republic of China | 2 |
| Xiangya Hospital of Central South University | 2 |
| Dongzhimen Hospital, Beijing | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebral Hemorrhage | 35 |
| Stroke | 7 |
| Ischemic Stroke | 4 |
| Brain Injuries, Traumatic | 3 |
| Subarachnoid Hemorrhage | 3 |
| Cerebral Infarction | 2 |
| Intracranial Hemorrhage, Hypertensive | 2 |
| Ischemic Attack, Transient | 2 |
| Sepsis | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.